This is a news story, published by Home | The George Institute for Global Health, that relates primarily to George Medicines news.
For more George Medicines news, you can click here:
more George Medicines newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Home | The George Institute for Global Health, you can click here:
more news from Home | The George Institute for Global HealthOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Blood Pressure Lowering Treatment Triallists. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Pharmacological blood pressure news, hypertension guidelines news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Hypertension TreatmentHome | The George Institute for Global Health
•91% Informative
Novel low-dose 3 -in-1 blood pressure pill significantly outperforms standard care, study shows.
Over 80% of patients achieved control within a month , sustained at six months .
GMRx2 is the leading drug candidate of George Medicines , a late-stage, biopharmaceutical company addressing significant unmet need in the treatment of cardiometabolic disease.
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
World Health Organization . Hypertension. 2023 . Accessed August 2024 .
Global burden of 87 risk factors in 204 countries and territories, 19902019 : a systematic analysis.
VR Score
94
Informative language
96
Neutral language
60
Article tone
formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
12
Source diversity
8
Affiliate links
no affiliate links